Healgen Scientific Gets De Novo Marketing Authorization for OTC COVID and Flu Test
Healgen Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test received FDA De Novo authorization for OTC use.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Covid 19 |
Healgen Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test received FDA De Novo authorization for OTC use.
Read MorePosted by Andy Lundin | Oct 1, 2024 | Molecular Diagnostics |
Researchers developed AI-powered PCR tech that improves DNA profiling, offering more reliable results for medical applications and more.
Read MorePosted by Andy Lundin | Sep 24, 2024 | Diagnostic Technologies |
A new study introduces a breath-based diagnostic tool for lower respiratory tract infections, offering an alternative diagnostic method.
Read MorePosted by Andy Lundin | Sep 24, 2024 | Accreditation, Company News |
COLA appointed Lynn Jeffers to its board of directors, bringing her extensive leadership experience in healthcare to support COLA.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Cancer |
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read More